tradingkey.logo

Tivic Health Systems Inc

TIVC

3.270USD

+0.050+1.55%
Horarios del mercado ETCotizaciones retrasadas 15 min
2.31MCap. mercado
PérdidaP/E TTM

Tivic Health Systems Inc

3.270

+0.050+1.55%
Más Datos de Tivic Health Systems Inc Compañía
Tivic Health Systems, Inc. is a commercial health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the United States directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
Información de la empresa
Símbolo de cotizaciónTIVC
Nombre de la empresaTivic Health Systems Inc
Fecha de salida a bolsaNov 11, 2021
Director ejecutivoMs. Jennifer Ernst
Número de empleados7
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 11
Dirección47685 Lakeview Blvd
CiudadFREMONT
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94538
Teléfono18882766888
Sitio Webhttps://tivichealth.com/
Símbolo de cotizaciónTIVC
Fecha de salida a bolsaNov 11, 2021
Director ejecutivoMs. Jennifer Ernst
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jennifer Ernst
Ms. Jennifer Ernst
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
706.00
--
Ms. Lisa Wolf
Ms. Lisa Wolf
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Director
Director
--
--
Mr. Dean Zikria
Mr. Dean Zikria
Director
Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Ms. Sheryle J Bolton
Ms. Sheryle J Bolton
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jennifer Ernst
Ms. Jennifer Ernst
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
706.00
--
Ms. Lisa Wolf
Ms. Lisa Wolf
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Director
Director
--
--
Mr. Dean Zikria
Mr. Dean Zikria
Director
Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Statera BioPharma, Inc
5.88%
Avenue Venture Opportunities Fund LP
4.82%
Ernst (Jennifer)
0.07%
Bambach (Kimberly Ann)
0.04%
Other
89.19%
Accionistas
Accionistas
Proporción
Statera BioPharma, Inc
5.88%
Avenue Venture Opportunities Fund LP
4.82%
Ernst (Jennifer)
0.07%
Bambach (Kimberly Ann)
0.04%
Other
89.19%
Tipos de accionistas
Accionistas
Proporción
Corporation
12.68%
Individual Investor
0.14%
Other
87.19%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
32
112.57K
12.82%
+62.78K
2025Q1
32
1.24K
0.18%
-48.58K
2024Q4
34
288.82K
2.82%
-516.93K
2024Q3
32
301.13K
4.87%
-468.33K
2024Q2
32
639.36K
10.34%
+419.46K
2024Q1
34
88.08K
6.01%
-141.85K
2023Q4
34
75.33K
5.40%
-149.34K
2023Q3
33
160.42K
18.20%
+130.18K
2023Q2
33
60.32K
19.16%
+13.93K
2023Q1
31
66.20K
21.11%
+34.42K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Statera BioPharma, Inc
61.20K
6.97%
+61.20K
--
May 14, 2025
Avenue Venture Opportunities Fund LP
50.13K
5.71%
+50.13K
--
May 14, 2025
Ernst (Jennifer)
706.00
0.08%
--
--
May 14, 2025
Bambach (Kimberly Ann)
442.00
0.05%
--
--
May 14, 2025
Gurfein (Blake Ph.D.)
66.00
0.01%
--
--
May 14, 2025
SBI Securities Co., Ltd.
16.00
0%
-2.00
-11.11%
Mar 31, 2025
BofA Global Research (US)
5.00
0%
+1.00
+25.00%
Mar 31, 2025
Susquehanna International Group, LLP
--
0%
-927.00
-100.00%
Dec 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Aug 22, 2023
Merger
100<1
Aug 22, 2023
Merger
100<1
Fecha
Tipo
Relación
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Mar 05, 2025
Merger
17<1
Aug 22, 2023
Merger
100<1
Aug 22, 2023
Merger
100<1
Aug 22, 2023
Merger
100<1
Aug 22, 2023
Merger
100<1
KeyAI